Filings Radar

SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.

Neuraxis, INC (NRXS)

CIK 0001933567 3 material events

Insider activity (SEC Form 4)

Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.

Open-market · last 30 days: 3 buyers bought $12K 0 sellers sold $0
Open-market · last 90 days: 3 buyers bought $12K 0 sellers sold $0
InsiderRoleDateTransactionSharesValue
Carrico Brian Allen Chief Executive Officer, Director 2026-10-08 Open-market buy 268 $1K
Carrico Thomas Joeseph CRO, CCO, CPO 2026-10-08 Open-market buy 328 $2K
Henrichs Timothy Robert Chief Financial Officer 2026-10-08 Open-market buy 1937 $9K
Carrico Brian Allen Chief Executive Officer, Director 2026-08-24 Grant/award 199188 —
Carrico Thomas Joeseph CRO, CCO, CPO 2026-08-24 Grant/award 193678 —
Miranda Adrian CMO, SVP Science & Tech 2026-08-24 Grant/award 199106 —
Aharon Gil Director 2026-08-13 Grant/award 43930 $276K
Ferge Kristin A Director 2026-08-13 Grant/award 31134 $196K
Keyser Jane Elizabeth Director 2026-08-13 Grant/award 26073 $164K
Watkins Bradley Mitchell Director 2026-08-13 Grant/award 26073 $164K
Aharon Gil Director 2026-07-29 Grant/award 2226 —
Aharon Gil Director 2026-07-29 Grant/award 40068 —
Aharon Gil Director 2026-04-28 Grant/award 12304 —
Aharon Gil Director 2026-04-28 Grant/award 221917 —
Carrico Brian Allen Chief Executive Officer, Director 2026-04-01 Open-market buy 8060 $16K
Carrico Thomas Joeseph CRO, CCO, CPO 2026-04-01 Open-market buy 667 $1K
Henrichs Timothy Robert Chief Financial Officer 2026-04-01 Open-market buy 7593 $15K
Hannasch Brian 10% Owner 2026-02-12 Open-market buy 40000 $197K
Hannasch Brian 10% Owner 2026-02-11 Open-market buy 40000 $186K
Aharon Gil Director 2026-01-22 Grant/award 21598 $100K
Most recent 20 reported transactions. Open-market buys (P) and sells (S) are the deliberate ones; grants and option exercises are compensation. Not investment advice.

Exec Compensation

8-K filed 2026-08-19 confidence 92%

The filing discloses multiple compensatory arrangements for named executives and directors: (1) a stock option exchange effective July 24, 2026, converting 1,319,394 options to RSUs for Brian Carrico (199,188 RSUs), Adrian Miranda (199,106 RSUs), and Thomas Carrico (193,678 RSUs) with immediate vesting; (2) RSU grants on August 13, 2026, to four named executives (Carrico, Henrichs, Miranda, Carrico) vesting over three years; and (3) one-time equity awards of 127,120 shares to independent directors. These are material compensatory arrangements affecting executive and director compensation under the 2022 Plan.

View raw filing on EDGAR →

Dividend Distribution

8-K filed 2026-07-10 confidence 95%

The filing discloses a stock dividend declaration by the Board of Directors on July 9, 2026, whereby holders of Series B Preferred Stock will receive shares of Common Stock based on accrued and unpaid dividends, with approximately 80,463 shares expected to be issued and payment scheduled for July 29, 2026. This is a material dividend distribution event requiring 8-K disclosure under Item 8.01.

View raw filing on EDGAR →

Shareholder vote

8-K filed 2026-06-12 confidence 98%

The filing discloses results of Neuraxis, Inc.'s annual meeting of stockholders held on June 10, 2026, under Item 5.07. It reports voting outcomes for four matters: election of six directors (all approved with >96% support), ratification of auditor Rosenberg Rich Baker Berman, P.A., amendment to the 2022 Omnibus Securities and Incentive Plan, and approval of the 2025 Employee Stock Purchase Plan. These are routine but material shareholder governance matters.

View raw filing on EDGAR →